Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors - PubMed (original) (raw)
. 1998 Jan 23;279(5350):577-80.
doi: 10.1126/science.279.5350.577.
K Isozaki, Y Moriyama, K Hashimoto, T Nishida, S Ishiguro, K Kawano, M Hanada, A Kurata, M Takeda, G Muhammad Tunio, Y Matsuzawa, Y Kanakura, Y Shinomura, Y Kitamura
Affiliations
- PMID: 9438854
- DOI: 10.1126/science.279.5350.577
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
S Hirota et al. Science. 1998.
Abstract
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the human digestive tract, but their molecular etiology and cellular origin are unknown. Sequencing of c-kit complementary DNA, which encodes a proto-oncogenic receptor tyrosine kinase (KIT), from five GISTs revealed mutations in the region between the transmembrane and tyrosine kinase domains. All of the corresponding mutant KIT proteins were constitutively activated without the KIT ligand, stem cell factor (SCF). Stable transfection of the mutant c-kit complementary DNAs induced malignant transformation of Ba/F3 murine lymphoid cells, suggesting that the mutations contribute to tumor development. GISTs may originate from the interstitial cells of Cajal (ICCs) because the development of ICCs is dependent on the SCF-KIT interaction and because, like GISTs, these cells express both KIT and CD34.
Similar articles
- Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas.
Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Lasota J, et al. Am J Pathol. 1999 Jan;154(1):53-60. doi: 10.1016/S0002-9440(10)65250-9. Am J Pathol. 1999. PMID: 9916918 Free PMC article. - Gastrointestinal stromal tumors: their origin and cause.
Hirota S. Hirota S. Int J Clin Oncol. 2001 Feb;6(1):1-5. doi: 10.1007/pl00012072. Int J Clin Oncol. 2001. PMID: 11706520 Review. - A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors.
Nakahara M, Isozaki K, Hirota S, Miyagawa J, Hase-Sawada N, Taniguchi M, Nishida T, Kanayama S, Kitamura Y, Shinomura Y, Matsuzawa Y. Nakahara M, et al. Gastroenterology. 1998 Nov;115(5):1090-5. doi: 10.1016/s0016-5085(98)70079-4. Gastroenterology. 1998. PMID: 9797363 - c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
Wardelmann E, Neidt I, Bierhoff E, Speidel N, Manegold C, Fischer HP, Pfeifer U, Pietsch T. Wardelmann E, et al. Mod Pathol. 2002 Feb;15(2):125-36. doi: 10.1038/modpathol.3880504. Mod Pathol. 2002. PMID: 11850541 - Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
Miettinen M, Lasota J. Miettinen M, et al. Arch Pathol Lab Med. 2006 Oct;130(10):1466-78. doi: 10.5858/2006-130-1466-GSTROM. Arch Pathol Lab Med. 2006. PMID: 17090188 Review.
Cited by
- Revolutionizing CAR T-Cell Therapies: Innovations in Genetic Engineering and Manufacturing to Enhance Efficacy and Accessibility.
Giorgioni L, Ambrosone A, Cometa MF, Salvati AL, Nisticò R, Magrelli A. Giorgioni L, et al. Int J Mol Sci. 2024 Sep 26;25(19):10365. doi: 10.3390/ijms251910365. Int J Mol Sci. 2024. PMID: 39408696 Free PMC article. Review. - Impact of systemic steroids on the efficacy of first line imatinib treatment of patients with advanced gastrointestinal stromal tumors (GISTs).
Kim S, Kim HD, Kim EJ, Ryu MH, Kang YK. Kim S, et al. BMC Cancer. 2024 Oct 8;24(1):1245. doi: 10.1186/s12885-024-13032-9. BMC Cancer. 2024. PMID: 39379868 Free PMC article. - Fourteen-year follow-up results of imatinib therapy in patients with unresectable and metastatic gastrointestinal stromal tumors.
Kanda T, Ichikawa H, Ishikawa T, Muneoka Y, Kano Y, Naito T, Suzuki S, Wakai T. Kanda T, et al. Int J Clin Oncol. 2024 Sep 30. doi: 10.1007/s10147-024-02631-y. Online ahead of print. Int J Clin Oncol. 2024. PMID: 39343814 - Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.
Trembath HE, Yeh JJ, Lopez NE. Trembath HE, et al. Cancer Treat Res. 2024;192:305-418. doi: 10.1007/978-3-031-61238-1_15. Cancer Treat Res. 2024. PMID: 39212927 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous